Drugs Made In America Acquisition II Corp. (DMII) stock
DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)
Close on Nov 17, 2026Market cap $140.36MP/E –Yield –
Drugs Made In America Acquisition II enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Drugs Made In America Acquisition II's enterprise value was $140.56M on Nov 11, 2026.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $140.56M | -8.7% |
| 2025 | Dec 31, 2025 | $153.88M | – |
See a number that looks wrong?